Company Profile

Codexis, Inc. (Nasdaq: CDXS) is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis, and the Company is currently developing its proprietary ECO Synthesis™ platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.

Latest Presentation

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC:
Commercial Physical and Biological Research (8731)

Contact Information

Investor Relations
Codexis, Inc.
Carrie McKim
200 Penobscot Drive
Redwood City, CA 94063
United States
T: 650-421-8399
ir@codexis.com

Company Contact
Codexis, Inc.
200 Penobscot Drive
Redwood City, CA 94063
United States
T: 650-421-8205
media@codexis.com